{"id":239234,"date":"2024-07-03T11:30:30","date_gmt":"2024-07-03T11:30:30","guid":{"rendered":"https:\/\/michigandigitalnews.com\/index.php\/2024\/07\/03\/this-cheap-biotech-offers-investors-a-play-on-als-if-trial-data-continues-to-impress\/"},"modified":"2025-06-25T17:15:36","modified_gmt":"2025-06-25T17:15:36","slug":"this-cheap-biotech-offers-investors-a-play-on-als-if-trial-data-continues-to-impress","status":"publish","type":"post","link":"https:\/\/michigandigitalnews.com\/index.php\/2024\/07\/03\/this-cheap-biotech-offers-investors-a-play-on-als-if-trial-data-continues-to-impress\/","title":{"rendered":"This cheap biotech offers investors a play on ALS if trial data continues to impress"},"content":{"rendered":"<p> [ad_1]<br \/>\n<br \/><img decoding=\"async\" src=\"https:\/\/images.mktw.net\/im-41235125\" \/><br \/>NeuroSense Therapeutics Ltd.\u2019s stock rose 6.5% Tuesday, as analysts cheered data from the biotech\u2019s late-stage trial of a treatment for the fatal disease amyotrophic lateral sclerosis, or ALS.<br \/>\n<br \/>[ad_2]<br \/>\n<br \/><a href=\"https:\/\/www.marketwatch.com\/story\/this-cheap-biotech-offers-investors-a-play-on-als-if-trial-data-continues-to-impress-1a38d55e?mod=mw_rss_topstories\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[ad_1] NeuroSense Therapeutics Ltd.\u2019s stock rose 6.5% Tuesday, as analysts cheered data from the biotech\u2019s late-stage trial of a treatment for the fatal disease amyotrophic<\/p>\n","protected":false},"author":1,"featured_media":239235,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[164],"tags":[],"_links":{"self":[{"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/posts\/239234"}],"collection":[{"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/comments?post=239234"}],"version-history":[{"count":0,"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/posts\/239234\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/media\/239235"}],"wp:attachment":[{"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/media?parent=239234"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/categories?post=239234"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/michigandigitalnews.com\/index.php\/wp-json\/wp\/v2\/tags?post=239234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}